TriangleLm-GUCY2C vaccine (NCT07417488)
Lm-GUCY2C vaccine trial for Colorectal Cancer and Small Bowel Adenocarcinoma (NCT07417488). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
Lo que dice el vídeo
Lee la transcripción
This trial is for advanced colorectal cancer and small bowel adenocarcinoma that has progressed on standard therapies, in adults.
The idea: a two step vaccine, called prime boost. First comes one injection into the muscle. Four weeks later, two doses by vein of a second vaccine, Lm GUCY2C, made from recombinant Listeria, at one of three rising dose levels.
This single center phase 1 trial plans 18 patients. The main measure is the rate of dose limiting toxicities, to find the recommended dose. At Thomas Jefferson University in Philadelphia, Babar Bashir leads it.
Public record; not medical advice.
¿Ya estás en un ensayo?
Se convierte en un proyecto que hay que manejar: citas, estudios de imagen, análisis, efectos secundarios y papeleo. Triangle lo mantiene organizado en un solo lugar, para ti o para quien te ayuda.
Organizar mi ensayoPrueba gratuita de 7 días, después $9 al mes. Cancela cuando quieras.
Cómo funcionan estos ensayos: qué es de verdad la fase 1 · preguntas frecuentes No es evidencia clínica.